Clinical studies recruiting near Dalian

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Validation of CAGIB Score for In-hospital Mortality of Cirrhotic Patients With Acute Gastrointestinal Bleeding
Phase N/A · The Six People's Hospital of Dalian · Xingshun Qi · NCT04662918 The Chinese Familial Alzheimer's Network
Phase N/A · Affiliated Zhongshan hospital of Dalian university · Capital Medical University · NCT03657732 Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective
NA · The First Affiliated Hospital of Dalian Medical University · Second Affiliated Hospital, Zhejiang University, School of M · NCT07402525 A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopa
Phase N/A · Local Institution - 0005 · Bristol-Myers Squibb · NCT07361289 Liposomal Amphotericin B Plus Posaconazole/Isavuconazole for Mucormycosis in Hematologic Malignancies: Efficacy and Safe
Phase N/A · The Second Hospital of Dalian Medical University · Institute of Hematology & Blood Diseases Hospital, China · NCT07185503 A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent
Phase 3 · Affiliated Zhongshan Hospital Of Dalian University · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT07003074 Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Phase N/A · Research Site · AstraZeneca · NCT06465810 Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy
Phase 3 · Affiliated Zhongshan Hospital Dalian University · Beletalent (Zhuhai) Pharmaceutical Co., Ltd · NCT06817265 Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
NA · The Second People&#39;s Hospital of Dalian · Peking Union Medical College Hospital · NCT05866029 The Prevalence of COPD in Patients With Cardiovascular Disease and the Benefit of Cardiopulmonary Co-management
NA · Research Site · AstraZeneca · NCT06909773 JS207 Combination Therapy in Triple-negative Breast Cancer
Phase 2 · The Second Hospital of Dalian Medical University · Shanghai Junshi Bioscience Co., Ltd. · NCT07045311 Prognostic Biomarkers for Selective Intra-Arterial Cooling Infusion Combined with Endovascular Thrombectomy in Acute Isc
Phase N/A · Dalian Municipal Central Hospital · Capital Medical University · NCT06665386 Ultra-early Identification of Futile Recanalization After Reperfusion Therapy in Acute Ischemic Stroke Based on Cerebral
Phase N/A · Dalian Municipal Central Hospital · Beijing Shijitan Hospital, Capital Medical University · NCT07556068 Real-world Study of Aflibercept 8 mg in nAMD
Phase N/A · Dalian No.3 People's Hospital · Peking University People's Hospital · NCT07640997 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · The Second Affiliated Hospital of Dalian Medical University · AbbVie · NCT04928846 Clinical Trial of TQB2922 for Injection in Patients With Advanced Cancers
Phase 1 · Affiliated Zhongshan Hospital of Dalian University · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06188624 Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemo
Phase 3 · Affiliated Zhongshan Hospital Of Dalian University · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07385703 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 A Prognostic Model for Drug-induced Liver Injury in China
Phase N/A · The Second Affiliated Hospital of Dalian Medical University · Beijing Friendship Hospital · NCT05060289 Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)
Phase 3 · Xinhua Hospital Affiliated to Dalian University · Beijing Tiantan Hospital · NCT06157502 Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative G
Phase 3 · The Second Hospital of Dalian Medical University · Sun Yat-sen University · NCT05918094 Full-Course ECMO Strategy for Moderate-to-Severe ARDS
NA · The Second Affiliated Hospital of Dalian Medical University · Southeast University, China · NCT07726953 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 Phase Ib/II Study of Vebreltinib With Furmonertinib in NSCLC Patients With c-Met Amplification After EGFR-TKI Failure
Phase 1/Phase 2 · The Second Hospital of Dalian Medical University · Peking University Cancer Hospital & Institute · NCT07087223 Different Doses of Dalpicicl Combined With Letrozole in the First-line Treatment of HR-positive, HER2-negative Advanced
Phase 2 · The Second Affiliated Hospital of Dalian Medical University · wanghaibo · NCT07285382 Efficacy of Montelukast on STEMl Patients
Phase 3 · Affiliated Zhongshan Hospital of Dalian University · Shanghai Zhongshan Hospital · NCT07320625 A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Met
Phase 1/Phase 2 · The Second Hospital To Dalian Medical University · Janssen Research & Development, LLC · NCT05379595 Early Detection of Advanced Adenomas and Colorectal Cancer
Phase N/A · The First Affiliated Hospital of Dalian Medical University · City of Hope Medical Center · NCT06342440 ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
Phase 2 · The Second Hospital of Dalian Medical University · Hansoh BioMedical R&D Company · NCT06007729 Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
NA · Affiliated Zhongshan Hospital of Dalian University · Stephen Nicholls · NCT05325034

Look up another city

Look up another condition